Sodium-Hydrogen Exchanger 3 Inhibitor
- Name
- Sodium-Hydrogen Exchanger 3 Inhibitor
- Accession Number
- DBCAT005885
- Description
Not Available
- Drugs
Drug Drug Description Tenapanor An NHE3 inhibitor indicated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic kidney disease, - Drugs & Drug Targets
Drug Target Type Tenapanor Sodium/hydrogen exchanger 3 target Tenapanor Cytochrome P450 3A4 enzyme Tenapanor Cytochrome P450 3A5 enzyme Tenapanor Solute carrier organic anion transporter family member 2B1 transporter